Exact Sciences Corp. will participate in the BofA Securities Health Care Conference in Las Vegas, with a fireside chat scheduled for May 15, 2024. Investors are invited to join the webcast available on the company's website.
Exact Sciences Corp. parteciperà alla Conferenza sulla Sanità di BofA Securities a Las Vegas, con un incontro informale previsto per il 15 maggio 2024. Gli investitori sono invitati a partecipare al webcast disponibile sul sito web dell'azienda.
Exact Sciences Corp. participará en la Conferencia de Salud de BofA Securities en Las Vegas, con una charla informal programada para el 15 de mayo de 2024. Se invita a los inversores a unirse a la transmisión por internet disponible en el sitio web de la compañía.
Exact Sciences Corp는 라스베이거스에서 열리는 BofA Securities 헬스케어 컨퍼런스에 참가하며, 2024년 5월 15일에 난로 옆 대화가 예정되어 있습니다. 투자자들은 회사 웹사이트에서 제공되는 웹캐스트에 참여할 수 있습니다.
Exact Sciences Corp. participera à la Conférence sur la Santé de BofA Securities à Las Vegas, avec une discussion informelle prévue pour le 15 mai 2024. Les investisseurs sont invités à rejoindre la webdiffusion disponible sur le site web de l'entreprise.
Exact Sciences Corp. wird an der BofA Securities Gesundheitskonferenz in Las Vegas teilnehmen, mit einem Kamingespräch, das für den 15. Mai 2024 geplant ist. Investoren sind eingeladen, sich über den auf der Website des Unternehmens verfügbaren Webcast zu beteiligen.
Positive
None.
Negative
None.
MADISON, Wis.--(BUSINESS WIRE)--
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.
BofA Securities Health Care Conference, Las Vegas Fireside chat on Wednesday, May 15, 2024 at 4:40 p.m. ET
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
